Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.21.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2021
Mar. 31, 2020
Current assets:    
Cash and cash equivalents $ 208.5 $ 144.4
Restricted cash and cash equivalents 5.0 5.0
Restricted cash and cash equivalents - Asbestos 104.9 36.4
Restricted short-term investments - Asbestos 26.6 21.6
Accounts and other receivables, net 333.2 363.3
Inventories 218.3 305.1
Prepaid expenses and other current assets 38.9 26.1
Insurance receivable - Asbestos 6.6 5.0
Workers’ compensation - Asbestos 1.6 1.5
Total current assets 943.6 908.4
Property, plant and equipment, net 1,372.3 1,341.7
Operating lease right-of-use-assets 46.4 40.5
Finance lease right-of-use-assets 2.7 1.7
Goodwill 209.3 196.9
Intangible assets, net 173.9 166.7
Insurance receivable - Asbestos 42.9 38.5
Workers’ compensation - Asbestos 20.3 20.7
Deferred income taxes 906.8 989.4
Deferred income taxes - Asbestos 367.4 319.1
Other assets 3.4 4.7
Total assets 4,089.0 4,028.3
Current liabilities:    
Accounts payable and accrued liabilities 307.0 274.7
Accrued payroll and employee benefits 112.5 87.1
Operating lease liabilities 7.8 14.3
Finance lease liabilities 1.0 0.5
Accrued product warranties 6.0 7.0
Income taxes payable 6.6 8.9
Asbestos liability 122.2 103.9
Workers’ compensation - Asbestos 1.6 1.5
Dividends payable 303.7 0.0
Other liabilities 32.7 12.1
Total current liabilities 901.1 510.0
Long-term debt 858.6 1,354.6
Deferred income taxes 86.3 81.9
Operating lease liabilities 53.3 41.4
Finance lease liabilities 1.9 1.5
Accrued product warranties 33.6 35.4
Income taxes payable 4.7 21.3
Asbestos liability 1,013.6 882.5
Workers’ compensation - Asbestos 20.3 20.7
Other liabilities 54.8 43.7
Total liabilities 3,028.2 2,993.0
Commitments and contingencies (Note 14)
Shareholders’ equity:    
Common stock, Euro 0.59 par value, 2.0 billion shares authorized; 444,288,874 shares issued and outstanding at 31 March 2021 and 443,144,740 shares issued and outstanding at 31 March 2020 231.4 230.6
Additional paid-in capital 224.6 207.3
Retained earnings 611.4 659.5
Accumulated other comprehensive loss (6.6) (62.1)
Total shareholders’ equity 1,060.8 1,035.3
Total liabilities and shareholders’ equity $ 4,089.0 $ 4,028.3